AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | +125.0% | 34,478 | +125.4% | 0.00% | – |
| Q2 2022 | $8,000 | -97.5% | 15,299 | -62.9% | 0.00% | -100.0% |
| Q4 2019 | $315,000 | -0.6% | 41,193 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $317,000 | -49.5% | 41,193 | -55.1% | 0.00% | -50.0% |
| Q2 2019 | $628,000 | -13.4% | 91,709 | +1.8% | 0.00% | -33.3% |
| Q1 2019 | $725,000 | -22.2% | 90,109 | -27.6% | 0.00% | -25.0% |
| Q4 2018 | $932,000 | -67.5% | 124,408 | -58.5% | 0.00% | -60.0% |
| Q3 2018 | $2,866,000 | -16.8% | 299,436 | -8.0% | 0.01% | -28.6% |
| Q2 2018 | $3,445,000 | – | 325,611 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |